학술논문

Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.
Document Type
Article
Source
Journal of Clinical Oncology; 9/10/2023, Vol. 41 Issue 26, p4218-4225, 16p
Subject
Language
ISSN
0732183X